PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) —
Kaskela Law LLC announces that it is investigating ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”) on behalf of the company’s investors.
Since May 2023, shares of ProPhase’s common stock have declined in value from a trading price of over $9.75 per share to a current trading price of less than $4.75 per share, a cumulative decline of over 51% in value.
The investigation seeks to determine whether the company’s officers and/or directors breached their fiduciary duties or violated the securities laws in connection with recent corporate actions.
ProPhase stockholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750, or by email (skaskela@kaskelalaw.com / abell@kaskelalaw.com) or online at https://kaskelalaw.com/cases/prophase-labs/ , for additional information about this investigation and their legal rights and options.
Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.
CONTACT:
KASKELA LAW LLC
D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com
This notice may constitute attorney advertising in certain jurisdictions.
- Black Opal Insurance Launches Investor-Focused Property Insurance Platform for Real Estate Pros - June 30, 2025
- Camfil Highlights Importance of Summer HVAC Maintenance for Better Learning Environments - June 30, 2025
- American Tungsten Corp. Announces Non-Brokered Private Placement of Shares - June 30, 2025
